RKV Rakovina Therapeutics Inc.

0.1084USD0.1550 CAD · TSXV+6.90%Mkt Cap: 2.65M USDP/E: —

Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems. It develops kt-2000 series, which are patented class…